Overview
Jillian Cameron practices in Melbourne, Australia. Ms. Cameron is rated as an Advanced expert by MediFind in the treatment of Epilepsy with Myoclonic-Atonic Seizures. Her top areas of expertise are Dentatorubral-Pallidoluysian Atrophy, Lafora Disease, Myoclonic Epilepsy, and Epilepsy with Myoclonic-Atonic Seizures.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Epilepsy with Myoclonic-Atonic Seizures.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Dentatorubral-Pallidoluysian AtrophyMs. Cameron isDistinguished. Learn about Dentatorubral-Pallidoluysian Atrophy.
- Lafora DiseaseMs. Cameron isDistinguished. Learn about Lafora Disease.
- Myoclonic EpilepsyMs. Cameron isDistinguished. Learn about Myoclonic Epilepsy.
- Advanced
- Epilepsy with Myoclonic-Atonic Seizures
- Experienced
- Absence SeizureMs. Cameron isExperienced. Learn about Absence Seizure.
- Batten DiseaseMs. Cameron isExperienced. Learn about Batten Disease.
- CLN1 DiseaseMs. Cameron isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseMs. Cameron isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseMs. Cameron isExperienced. Learn about CLN3 Disease.
- CLN4 DiseaseMs. Cameron isExperienced. Learn about CLN4 Disease.